Antibacterial and pro-osteogenic effects of β-Defensin-2-loaded mesoporous bioglass

• Published in: Dental Materials Journal Vol. 40; no. 2; pp. 464 - 471
• Main Authors: REN, Le, ZHANG, Zhe, DENG, Chunni, ZHANG, Nan, LI, Daxu
• Format: Journal Article
• Language: English
• Published: Japan The Japanese Society for Dental Materials and Devices 25.03.2021
• Subjects: Anti-Bacterial Agents - pharmacology; Antibacterial; beta-Defensins - pharmacology; Bone regeneration; Ceramics; Dentistry; Glass; Humans; Mesoporous bioglass; Osteogenesis; Porosity; Tissue Scaffolds; β-Defensin-2; Mesoporous bioglass; β-Defensin-2; Antibacterial; Bone regeneration
• ISSN: 0287-4547; 1881-1361
• DOI: 10.4012/dmj.2020-105

The human antimicrobial peptide beta-defensin-2 (hBD2) shows broad antibacterial activity and infrequent bacterial resistance. Here mesoporous bioactive glass (MBG) was loaded with hBD2, forming hBD2-loaded MBG (BD-MBG). The antibacterial and osteogenic effects of BD-MBG were investigated in comparison with MBG and the blank control (BC). The result showed that BD-MBG yielded sustained hBD2 release for more than 7 weeks in vitro, and resulted in significantly lower amounts of viable bacteria and colony forming units, and significantly higher levels of bacterial protein release compared with those in the BC and MBG groups (all p<0.05). Compared with that in the BC group, significantly higher bone marrow stromal cell (BMSC) proliferation rates, alkaline phosphatase (ALP) activity, calcium nodule formation, and expression levels of early and late osteogenic makers were observed after MBG and BD-MBG treatments (p<0.05). Thus, BD-MBG inhibited bacterial growth, damaged their membrane, and promoted early and late osteogenic BMSC differentiation.